| ASSET | YEAR | % RETURN |
|---|---|---|
Axsome Therapeutics (AXSM) | 2015 | 3% |
Axsome Therapeutics (AXSM) | 2016 | -29.25% |
Axsome Therapeutics (AXSM) | 2017 | -20% |
Axsome Therapeutics (AXSM) | 2018 | -50.09% |
Axsome Therapeutics (AXSM) | 2019 | 3,578.29% |
Axsome Therapeutics (AXSM) | 2020 | -22.18% |
Axsome Therapeutics (AXSM) | 2021 | -53.54% |
Axsome Therapeutics (AXSM) | 2022 | 103.35% |
Axsome Therapeutics (AXSM) | 2023 | 2.43% |
Axsome Therapeutics (AXSM) | 2024 | 7.65% |
Axsome Therapeutics (AXSM) | 2025 | 24.06% |
